AT1 receptor antagonism modulates smooth muscle cell phenotype toward the contractile type more effectively than ACE inhibition in hypertensive rat hearts, independent of blood pressure lowering.
No takes yet. Share an insight, caveat, or question.
May support AT1-specific SMC modulation beyond BP control in hypertensive models; leaves open clinical translation.
Kubo et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: